Use of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days
Widmer K, Schmidt S, Bakel LA, Cookson M, Leonard J, Tyler A. Use of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days. Hosp Pediatr. 2021 Mar;11(3):223-230. doi: 10.1542/hpeds.2020-000380. PMID: 33597148; PMCID: PMC8287898
